1,862 recalls tagged with “stop use immediately”.
Philips Medical Systems recalled 313 cardiac monitors on September 3, 2025, due to a BIOS battery issue. The battery may deplete unexpectedly, halting the device's start-up process without warning. Patients and healthcare providers must stop using the device immediately.
Philips Medical Systems Nederland B.V. recalled eight Allura Xper FD20/15 OR Tables on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This recall affects two units in the U.S. and six units internationally.
Philips Medical Systems Nederland B.V. recalled 5,067 Allura Xper FD20 devices on September 3, 2025. The BIOS battery may deplete unexpectedly, halting the system's start-up process. This issue affects models 722006, 722012, and 722028 and poses a high risk to patient safety.
Inpeco S.A. recalled one unit of the FlexLab X (FXX) System on September 3, 2025. The recall affects the Sample Integrity Module, which has not been FDA evaluated for safety. This may cause erroneous results or delays in patient testing.
Philips Medical Systems Nederland B.V. recalled 87 Allura Xper FD20/10 medical imaging devices on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system's start-up process without warning. Healthcare providers and patients should stop using these devices immediately.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20 Biplane OR Table on September 3, 2025, due to a potential BIOS battery failure. The recall affects four units distributed globally, including two in the U.S. and two internationally.
New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder on September 3, 2025. The recall is due to undeclared milk allergen ingredients. Consumers should stop using the product immediately.
Glenmark Pharmaceuticals recalled 26,928 packs of Viorele oral contraceptives on September 3, 2025. The recall follows the discovery of impurity issues in the product. Consumers should stop using the affected tablets immediately and contact healthcare providers for guidance.
Major Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination concerns. A foreign substance was found in the packaging material, although the tablets themselves remain unaffected. Consumers should stop using the product immediately and consult healthcare providers.
LeMaitre Vascular recalled 28 units of Artegraft Collagen Vascular Grafts on September 2, 2025. The recall affects multiple model numbers due to unapproved sourcing of raw materials. Patients and healthcare providers must stop using the device immediately and follow recall instructions.
Canon Medical System recalled eight digital radiography systems on September 2, 2025. The software issue may leave X-ray areas partially covered by static images. Users should stop using the device immediately and follow recall instructions.
AvKARE recalled 2,192 cartons of Norgestimate and Ethinyl Estradiol Tablets on September 2, 2025. The tablets failed content uniformity specifications, posing a high hazard risk. Consumers should stop using the product immediately and consult their healthcare provider.
Fagron Compounding Services recalled 109,320 syringes of bevacizumab (Avastin) on August 29, 2025. The recall follows a lack of assurance of sterility, posing a high health risk. Consumers and healthcare providers should stop using the product immediately.
BigTree Sales Inc. recalled a handheld ultraviolet-C germicidal wand on August 29, 2025, due to unsafe levels of UVC radiation. The product can cause skin and eye injuries to users and nearby individuals. Consumers must stop using the device immediately and follow the manufacturer's instructions.
Herbal Creations recalls 19,425 kilograms of bulk colostrum powder distributed to 30 US customers after a milk allergen labeling error. The product label does not declare milk as an allergen. Consumers who purchased this product should not consume it and should contact Herbal Creations USA for refund or replacement.
Baxter Healthcare recalled 958,351 IV solution sets on August 29, 2025. The products may leak, posing a high risk to patients. Healthcare providers and patients must stop using these devices immediately.
Baxter Healthcare recalled 1,167,120 units of its CLEARLINK SYSTEM CONTINU-FLO Solution Set on August 29, 2025. The recall affects IV sets due to a risk of leakage that could pose serious health risks. Patients and healthcare providers should stop using these devices immediately.
Baxter Healthcare recalled 106,176 units of the CLEARLINK SYSTEM CONTINU-FLO Solution Set on August 29, 2025. The recall follows reports that the IV sets may leak, posing a high risk to patients. Healthcare providers and patients must stop using the device immediately.
Baxter Healthcare recalled 15,552 IV extension sets on August 29, 2025, due to a leak risk. The recall affects products distributed nationwide across 50 states. Healthcare providers and patients must stop using the devices immediately.
Northeast Scientific recalled 795 units of its Turbo-Elite Laser Atherectomy Catheter on August 29, 2025. The recall follows concerns about breaches in the sterile barrier packaging. This issue compromises the sterility assurance of the device.